ARCHIVES

Darbepoetin Didn’t Decrease Blood Transfusions, Lowered Overall Survival, Study Finds

This article is from The Cancer Letter archive.

Vol. 30 No. 4 | April 27, 2007

Download PDF Visit The Full Archive

Related Articles

Includes 8-page Business & Regulatory Report.

April 11, 2003

Challoner: We Recommended FDA Replace 510(k) Clearance

July 4, 2014

Also Von Eschenbach role in industry program raises new concerns of conflict of interest.

November 23, 2005

FDA Codifies Rules For Expanded Access, Charging For Drugs In Clinical Trials.

December 22, 2006

NCI Largely Unaffected By NIH Translational Research Center

February 11, 2011

RFAs Available: Silicone And Immune Response; Role Of Metallotionein; Dietary Fat Biomarkers

September 11, 1992